BridgeMD
Questionary to Fentanyl Nasal (F-PUFF) Spray Efficiancy and Safety
EU CTIS ID: 2024-519131-42-02
What this study is testing
Questionary to Fentanyl Nasal Spray Efficiancy and Safety
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- OVER 18 YEARS CANCER PATIENTS UNDER PAIN THERAPY
- We consider the study to be professionally based only among patients who are treated with F-puff according to the simplified off label recommendation, under routine treatment. Please amend the inclusion criteria with the following: - Patients with severe cancer, where beyond the standard pain relief therapy, severe, acute pain (breakthrough pain) occurs, and who were diagnosed with cancer according to the simplified off label access recommendation by HU NCA (NNGYK) (case number: NNGYK/GYSZ/40594-2/2024).
- major opioid therapy
- clear state of mind
- they can use the nasal spray by themselfes
- not pregnant, not breastfeeding
You likely can't join if
- YOUNGER THAN 18 YEARS OLD
- no malignacy
- Week lung capacity where assisted respiration is not needed (due to the respiration depressant effect of drugs with morphymomethic nature)
- Hypersensitivity to fentanyl or to any opioids.
See the full eligibility criteria
- OVER 18 YEARS CANCER PATIENTS UNDER PAIN THERAPY
- We consider the study to be professionally based only among patients who are treated with F-puff according to the simplified off label recommendation, under routine treatment. Please amend the inclusion criteria with the following: - Patients with severe cancer, where beyond the standard pain relief therapy, severe, acute pain (breakthrough pain) occurs, and who were diagnosed with cancer according to the simplified off label access recommendation by HU NCA (NNGYK) (case number: NNGYK/GYSZ/40594-2/2024).
- major opioid therapy
- clear state of mind
- they can use the nasal spray by themselfes
- not pregnant, not breastfeeding
- no cancerous tumour in mouth or nose
- breath count above 10/min
- no known fentanyl allergy
- YOUNGER THAN 18 YEARS OLD
- no malignacy
- Week lung capacity where assisted respiration is not needed (due to the respiration depressant effect of drugs with morphymomethic nature)
- Hypersensitivity to fentanyl or to any opioids.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.